What it is: Aviilx_long™ is a nine-ingredient post-viral recovery formula from Panaxea International, combining standardized botanicals and L-Tryptophan to address the multi-system burden of post-viral syndrome — cardiovascular, neurological, pulmonary, and psychiatric. Key standardizations include Artemisinin, Baicalein, Icariin, and Tenuigenin. Manufactured to Australian Pharmaceutical GMP standards for exclusive practitioner-directed use. How it works: Each ingredient targets a distinct dimension of post-viral pathology. Artemisinin suppresses NF-κB and STAT3 inflammatory signaling and inhibits viral replication. Baicalein blocks viral 3CL protease and helicase while suppressing NLRP3 inflammasome activation. Angelica keiskei chalcones address microclotting, vascular endothelial injury, and systemic inflammation. Luteolin stabilizes mast cells and suppresses neuroinflammation. Saffron supports serotonergic and dopaminergic mood recovery and neuroprotection. Polygala tenuifolia upregulates BDNF and modulates the HPA axis. Gardenia jasminoidin crosses the blood-brain barrier to reduce microglial neuroinflammation. Glycyrrhizin provides direct antiviral activity and adrenal cortisol support. L-Tryptophan restores serotonin and melatonin biosynthesis disrupted by viral neurological involvement. When to use it: Indicated for adult clients with post-viral multi-system symptoms — cognitive fog, fatigue, cardiovascular inflammatory burden, mood disturbance, neurological symptoms, and immune dysregulation. One capsule twice daily with food. Contraindicated with concurrent SSRIs or SNRIs without oversight, during pregnancy, and in clients with hypertension.
